Buscar
Tonix Pharmaceuticals Holding Corp
TNXPAñadir a la lista de seguimiento
11.870USD
-0.410-3.34%
Cierre 09-11 16:00（ET）
198.99MCap. mercado
PérdidaP/E TTM
Más Datos de Tonix Pharmaceuticals Holding Corp Compañía
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.
Perfil de Tonix Pharmaceuticals Holding Corp
Símbolo de cotizaciónTNXP
Nombre de la empresaTonix Pharmaceuticals Holding Corp
Fecha de salida a bolsaMar 29, 2010
Director ejecutivoLederman (Seth)
Número de empleados81
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 29
Dirección26 Main Street, Suite 101
CiudadCHATHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07928
Teléfono12129809155
Sitio Webhttps://www.tonixpharma.com/
Símbolo de cotizaciónTNXP
Fecha de salida a bolsaMar 29, 2010
Director ejecutivoLederman (Seth)
Ejecutivos de Tonix Pharmaceuticals Holding Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Dr. Gregory M. (Greg) Sullivan, M.D.
Dr. Gregory M. (Greg) Sullivan, M.D.
Secretary
Secretary
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Tonix Pharmaceuticals Holding Corp?
Los cinco principales accionistas de Tonix Pharmaceuticals Holding Corp son: Dr. Seth Lederman, M.D.
¿Cuántas instituciones poseen acciones de Tonix Pharmaceuticals Holding Corp (TNXP)?
A fecha de 2026Q1, 177 instituciones poseen acciones de Tonix Pharmaceuticals Holding Corp, con un valor de mercado combinado de aproximadamente 4.66M, lo que representa el 32.65% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 2019652.00.